Picture [iito] Fighting Customers 650x80px
Organisation › Details

Advanced Accelerator Applications USA Inc.

Advanced Accelerator Applications (AAA) is a European pharmaceutical company founded in 2002 to develop innovative diagnostic and therapeutic products. AAA's main focus is in the field of Molecular Imaging and targeted, individualized therapy for the management of patients with serious conditions (Personalized Medicine). AAA currently has 17 production and R&D facilities able to manufacture both diagnostics and therapeutic MNM products, and has over 270 employees in 10 countries (France, Italy, Germany, Switzerland, Spain, Poland, Portugal, Israel, U.S., Canada). In 2013 AAA is expecting to reach revenues of €56.6 million (+27% vs. 2012) and EBITDA of €14 million (+49% vs. 2012). *


Period Start 2016-10-06 existent
  Group Novartis (Group)
Products Industry molecular imaging
Region Region New York, NY
  Country United States (USA)
  Street 350 FIfth Avenue
The Empire State Building, Suite 6902
  City 10118 New York, NY
  Tel +1-212-235-2380
    Address record changed: 2018-07-24
Basic data Employees n. a.
  Currency EUR
  Annual sales 109,000,000 (sales (2016) 2016-12-31)
    * Document for �About Section�: Advanced Accelerator Applications S.A.. (2/17/14). "Press Release: Advanced Accelerator Applications Completes €41 Million Fund Raising". Saint-Genis-Pouilly.
Record changed: 2019-07-13


Picture [iito] No Tracking 650x80px

More documents for Novartis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top